Phase I/II Study to a Assess the GBS-06 Vaccine Manufactured by Inventprise, Inc., in Healthy, Non-Pregnant, Adult Women of Childbearing Age.

Phase 1/2 Active not recruiting 600 enrolled Inventprise Inc. PATH · collab

RandomizedParallel-groupQuadruple-blindPrevention

Summary

To assess the safety and tolerability of IVT GBS-06 vaccine administered as a single-dose regimen, at three dosage levels in healthy, non-pregnant, adult women of childbearing age (WOCBA).

Timeline

Start: 2024-11-12
Primary completion: 2025-08-26
Completion: 2026-02

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	IVT GBS-06	Vaccine	0.5 ml	Intramuscular

Phase I/II Study to a Assess the GBS-06 Vaccine Manufactured by Inventprise, Inc., in Healthy, Non-Pregnant, Adult Women of Childbearing Age.

Summary

Timeline

Drugs

Indications